For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of Tafamidis and the formulated version represents a true advancement . These novel therapies protect the transthyretin protein, preventing its damaging build-up and alleviating the bur